Skip to main contentSkip to navigation
Sirius Investors
Interpace Biosciences, Inc.

Interpace Biosciences, Inc.

IDXG
OTCHealthcare

Revenue Analysis - IDXG

Comprehensive quarterly and annual revenue breakdown by product lines and geographic regions to identify growth drivers and market opportunities.

IDXG Corporation

Annual

Revenue by Product Line

Latest quarterly revenue breakdown by product segments

Quarterly Product Revenue

Product Revenue Details

Detailed breakdown of revenue by product line

Commercial Services

0.0% of total revenue

$34.1M

Interpace Diagnostics

0.0% of total revenue

$2.5M

Historical Revenue Data

Quarterly product revenue breakdown over time (Last 6 records)

Date
Commercial Services
Interpace Diagnostics
Marketing Services
Product Commercialization
Sales Services
9/30/2015$34.1M$2.5M$0$0$0
6/30/2015$34.1M$2.3M$0$0$0
3/31/2015$36.2M$2.1M$0$0$0
9/30/2014$0$0$1.0M$53.0K$28.2M
6/30/2014$0$0$614.0K$2.9M$28.1M
3/31/2014$0$0$1.0M$3.0M$28.8M

Revenue Trend Analysis

Analysis of major growing and declining segments based on recent revenue data

Product Segments

Growing Segments
Interpace Diagnostics+11.2%

Earnings Reports

Want to see how IDXG's earnings relate to revenue? View quarterly earnings results, EPS history, and earnings surprises to understand the company's profitability.

View Earnings Reports